Researchers continue to excited about the medication , a innovative dual agonist showing significant outcomes in clinical trials for weight loss . It works by targeting both pathways : GLP-1 and GIP, https://faypvrl765026.frewwebs.com/39981846/the-new-possibility-for-body-management